Final Results of the Randomised Evaluation of Short-Term Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Treated With a New-Generation Stent (REDUCE Trial)

EuroIntervention - France
doi 10.4244/eij-d-19-00539
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Europa Digital & Publishing

Related search

The Underutilisation of Dual Antiplatelet Therapy in Acute Coronary Syndrome

International Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Factors Associated With Platelet Reactivity During Dual Antiplatelet Therapy in Patients With Diabetes After Acute Coronary Syndrome

Scientific Reports
Multidisciplinary
2020English

Sex-Specific Differences in Antithrombotic Therapy and Prognosis in Patients With Acute Coronary Syndrome Treated With Stent

Archivos de cardiolog�a de M�xico (English ed. Internet)
2020English

One-Year Clinical Outcomes of Patients With Versus Without Acute Coronary Syndrome With 3-Month Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Stent Implantation

PLoS ONE
Multidisciplinary
2020English

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Duration of Dual Antiplatelet Therapy in Patients Treated With Percutaneous Coronary Intervention for Coronary Chronic Total Occlusion

PLoS ONE
Multidisciplinary
2017English

Antiplatelet Therapy in Acute Coronary Syndrome

Continuing Cardiology Education
2017English

Bare Metal Stent Thrombosis in Patients With Acute Coronary Syndrome

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Statins Therapy Can Reduce the Risk of Atrial Fibrillation in Patients With Acute Coronary Syndrome: A Meta-Analysis

International Journal of Medical Sciences
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy